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ABSTRACT 
Inconsistent post-anesthetic advice imparted to breastfeeding mothers leads to unnecessary 
weaning or premature abandonment of nursing. This Doctoral of Nurse Practice (DNP) project 
set out to identify evidence-based research regarding post-anesthetic advice to communicate to 
breastfeeding mothers from their anesthesia providers. The first phase of the project involved the 
systematic development of a Clinical Practice Guideline (CPG) based on current evidence in the 
literature. The second phase of the project was the appraisal of the developed CPG by an 
interdisciplinary panel utilizing the AGREE II instrument. The overall quality of the developed 
guideline resulted in a combined score of 92%, representative of a high-quality guideline. 
Appraiser’s judgment concerning recommended use of the developed guideline resulted with an 
answer of ‘Yes’ to the recommended use of the guideline. The overwhelming evidence suggests 
that drugs administered to a breastfeeding mother during the perioperative period are not harmful 
and will not precipitate adverse outcomes in the healthy breastfed infants (Dalal, Bosak, & 
Berlin, 2014). A breastfeeding mothers return to baseline mentation and strength, suggest drug 
redistribution from plasma and milk, and termination of drug action (Cobb et al., 2015). Mothers 
are encouraged to continue breastfeeding and disregard the past recommendation to “pump and 
dump.” The American Academy of Pediatrics Committee on Drugs surmises, “The benefits of 
breastfeeding outweigh the risk of exposure of most therapeutic agents via breastmilk” (Sachs, 
2013, p. 805). 
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INTRODUCTION 
Inconsistent and often conflicting post-anesthetic advice imparted to breastfeeding 
mothers leads to unnecessary weaning or premature abandonment of nursing. The information in 
regards to the resumption of breastfeeding and milk discards can vary depending on anesthesia 
provider opinion, medical facility protocol, or the favored medically endorsed guideline. 
Furthermore, anesthesia providers, hospitals, and patients may rely on conservative and often 
restrictive recommendations given by drug manufacturers that may not accurately reflect 
conditions for lactating women and the transfer of anesthesia and analgesia medications into 
breast milk (Cobb, Liu, Valentine, & Onuoha, 2015).  
Concerns regarding the uptake of anesthetic agents into breast milk and potential 
pharmacological side effects passed to the breastfeeding infant influences anesthesia providers’ 
recommendations for the resumption of breastfeeding. Unwarranted fear of lasting sedative 
effects to the nursing infant and the possibility of delayed brain development has resulted in 
some anesthesia providers recommending that mothers discard breast milk and delay resumption 
of breastfeeding for up to 24 hours after anesthesia.  
Lack of clarity and inconsistent recommendations place unnecessary stress on this 
population and are a potential barrier for breastfeeding mothers. Mothers who require anesthesia 
may abandon nursing based on overly conservative and outdated advice from their anesthesia 
providers leading to unfortunate outcomes for both mother and baby. For these reasons, this DNP 
project identified evidenced-based research regarding post-anesthetic advice to be imparted to 
breastfeeding mothers from their anesthesia providers.  
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Local Problem 
Breastfeeding mothers who required surgery, at a community hospital in Arizona, were 
not provided consistent, evidence-based recommendations for the resumption of breastfeeding 
following anesthesia. Often mothers were advised to express their milk by way of a mechanical 
breast pump and dispose of the milk for the first 24 hours following anesthesia. Current evidence 
supports that once a mother is awake and alert, she may resume breastfeeding (Cobb et al., 
2015). According to the American Academy of Pediatrics (2012), maternal anesthesia is rarely a 
contraindication to breastfeeding, and that a healthy, term neonate can resume breastfeeding once 
their mother is awake, alert, and able to hold them. Furthermore, the recommendation to pump 
and discard breast milk for up to 24 hours after anesthesia is only warranted in the preterm infant 
or otherwise compromised neonate (American Academy of Pediatrics, 2012).  
The Significance of the Project to Anesthesia Providers and Healthcare 
Breastfeeding has a profound impact on both mother and child. Evidence confirms that 
breastfeeding is the healthiest, safest, and best source of infant nutrition (Breastfeeding, 2015). 
The long-term benefits to the mother after breastfeeding include decreased risk of reproductive 
cancers, psychological benefits, and optimal metabolic profile. A child who receives breast milk 
has a reduced risk of atony, obesity, metabolic, and immunologic disorders. Despite the 
recognized evidence that breastfeeding saves lives and reduces the disease burden for both 
mother and baby, mothers continue to confront barriers to breastfeeding (Office of the Surgeon 
General, 2011).  
This DNP project intended to present current evidence-based recommendations for the 
resumption of breastfeeding following anesthesia. To improve the clinical practice for anesthesia 
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providers counseling breastfeeding mothers, serving to remove barriers to breastfeeding and 
improve maternal and infant health outcomes.  
Purpose 
The purpose of this project was to furnish anesthesia providers with current research of 
anesthetic drugs and their transfer to breast milk. This project aimed to provide evidence-based 
recommendations to anesthesia providers regarding instructions on breastfeeding after 
anesthesia. Updating current practice will result in consistent information relayed to the 
breastfeeding mother, which may help reduce anxiety in this population and ultimately improve 
satisfaction and outcomes.  
THEORETICAL FRAMEWORK  
Rogers Diffusion of Innovation Theory of Organizational Change  
A theoretical framework guides the researcher on their quest of innovation adoption. 
Failure of evidence-based research to progress from experimentation to true adoption within an 
organization is associated with inadequate project planning and training, resistance to change, 
and lack of support. Rogers' Diffusion of Innovation Theory of Organizational Change provided 
unity and infrastructure for designing the implementation strategy and served as the conceptual 
framework for this DNP project. Defining the theory of research and clinical practice strengthens 
the probability of successful project implementation and adoption (Eldridge, 2013).  
There is a positive correlation between the rate of innovation adoption and response of 
the individuals within the healthcare system (Crowell, 2016). Constructs supplied by Rogers' 
theory aid in understanding barriers to innovation adoption and strategies to mitigate those 
barriers. There are negative forces that present barriers to the adoption of change. Individuals 
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who are resistant to change are laggards, whereas those that are open to innovation are early 
adopters. Early adopters are opinion leaders, individuals that are highly influential within an 
organization and can motivate others to adopt new concepts. Rogers’ framework explains that 
innovation diffusion begins with the change agent attempting to influence others to adopt the 
innovation (Crowell, 2016). This DNP student, as the change agent, fostered an environment of 
collaboration and openness. The change agent worked within the complex social system, 
utilizing early adopters to champion innovation diffusion. These early adopters influence the late 
majority and the lagers, those that are uncomfortable or resistant to change to align (Rogers, 
1995). Appreciation and promotion of a social structure that facilitates diffusion is essential for 
successful project adoption. Rogers’s theory helped in the identification of those individuals that 
supported the project momentum and aided in the adoption of new practice recommendations for 
the resumption of breastfeeding after anesthesia.  
Concepts 
A professor of communication, Everett Rogers, theorized on the rate of adoption by 
individuals within an organization when faced with change or innovation (Melnyk & Fineout-
Overholt, 2011). The five main constructs of Rogers’s Diffusion of Innovation Model describe 
the process by which innovation flows through a social system network over time and leads to 
adoption (Figure 1).  
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FIGURE 1. Stages of innovation adoption. (Modified from Crowell, D. M. (2016). Complexity leadership: 
Nursing’s role in health care delivery (2nd ed.). Philadelphia, PA: F.A. Davis Company.) 
Knowledge. The knowledge stage is the creation of awareness. The anesthesia provider 
gained an understanding of current evidence-based recommendations for the resumption of 
breastfeeding after anesthesia. The spread of knowledge results in improved patient satisfaction 
and health outcomes for both mother and baby.  
Persuasion. Persuasion is the stage where the anesthesia provider accepts current 
evidence-based recommendations for the resumption of breastfeeding. Providing anesthesia 
providers with current evidence of anesthetic drugs and their transfer to breast milk satisfies the 
need for knowledge with the ultimate goal to shape attitudes and the advice provided to 
breastfeeding patients.  
Decision. The decision stage manifests as the anesthesia provider forming an attitude 
toward the current evidence and the decision to accept the recommendations. Failure to adopt 
current recommendations is mitigated by strategic planning and compressive training that aims to 
demonstrate the vital impact of consistent information relayed to the breastfeeding mother which 
overall may help reduce anxiety in this population. 
Implementation. Implementation is the stage where the anesthesia provider begins to 
supply their breastfeeding mothers with consistent, evidence-based recommendations for the 
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resumption of breastfeeding. During this stage, the anesthesia provider will determine if these 
recommendations are helpful to their patients and if they warrant current use.  
Conformation. Both the individual anesthesia provider and the group of anesthesia 
providers as a whole choosing to adopt and utilize the recommendations when advising their 
patients on to the resumption of breastfeeding after anesthesia mark confirmation.  
SYNTHESIS OF EVIDENCE  
A literature review identified current evidence in regards to anesthetic drug diffusion into 
breast milk and recommendations for breastfeeding mothers who require anesthesia. The 
following online literature archives were utilized; PubMed, Cumulative Index to Nursing and 
Allied Health Literature (CINAHAL), and Excerpta Medical dataBASE (EMBASE). Key terms 
used for the search included breastfeeding, and general anesthesia, anesthetic agents, analgesic 
agents, infant drug exposure, breast milk transfer, and medication. Additional inclusion criteria 
included articles published after 2013; English language, human subjects, and randomized 
clinical research studies. The outcome was 15 articles, with all studies focused on labor-related 
analgesia and anesthesia. Broadening inclusion criteria to articles published in the last ten years 
and non-randomized clinical research resulted in 33 articles.  
Ethical constraints and difficulty recruiting nursing mothers and infants for controlled 
studies limit current research information. A large portion of literature about this topic did not 
qualify for inclusion based on publishing dates greater than 10 years. The peer-reviewed 
database LactMed®, provided by the National Institute of Health (NIH), was employed for the 
additional literature search. The database provides a synthesis of validated scientific literature 
regarding drugs and other chemicals to which breastfeeding mothers may be exposed to, levels 
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of such substances found in breast milk after maternal administration, and possible adverse 
effects in the nursing infant (LactMed®, 2017).  
Critical appraisal of evidence is necessary to ascertain the strength and weakness of 
current research and determine transferability into clinical practice. Ten articles (Appendix E) 
from the literature search met the rigor of this review, based on their relevancy, validity, and 
reliability.  
Strengths 
A seven-level hierarchy presented by Polit and Beck (2012) was utilized to assign a level 
of evidence based on the strength and quality of evidence provided. Evidence retrieved included 
one randomized control trial (Level II), cohort studies and non-randomized control trials (Level 
III), and observational and case studies (Level IV). Levels of evidence, based on the source of 
evidence was fair concerning a lack of randomized control trials related to a preponderance of 
benefit over harm. 
There is objective evidence and extensive research concerning drug chemistry and factors 
that influence maternal drug transfer into breast milk and subsequent infant exposure to said 
drugs. The overwhelming evidence suggests that drugs administered to a breastfeeding mother 
during the perioperative period will not precipitate adverse outcomes in the healthy breastfed 
infant (Dalal, Bosak, & Berlin, 2014). A breastfeeding mothers’ return to baseline mentation and 
strength suggests drug redistribution from plasma and milk, and termination of drug action 
(Cobb et al., 2015). Furthermore, there is no required waiting period or discarding of milk 
necessary before the resumption of breastfeeding once a mother has recovered from general 
anesthesia (Chu et al., 2013; Dalal et al., 2014; Kelly et al., 2012; Shergill et al., 2012). In most 
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cases, general anesthesia is administered for a short period utilizing a combination of anesthetic 
agents. When delivering a combination of anesthetic agents, several authors suggest to adhere to 
the recommendations for the most problematic medication used during the procedure; caution is 
advised for anesthetic agents with prolonged half-lives and potent metabolites that may lead to 
drug accumulation (LactMed®, 2017; Sachs, 2013; Shergill et al., 2012). The American 
Academy of Pediatrics Committee on Drugs surmises, “The benefits of breastfeeding outweigh 
the risk of exposure of most therapeutic agents via breastmilk” (Sachs, 2013, p. 805).  
Weaknesses 
Weaknesses identified in the literature include a limited pool of current high-level 
research studies, finding that most notable and established studies concerning breastfeeding and 
anesthetic agents were published over a decade earlier. Due to ethical constraints and the 
considerably small population of breastfeeding mothers who require general anesthesia, there is a 
scarcity of large or robust studies in this population. Current scientific literature is limited to 
observational studies, retrospective cohort studies, case studies, and literature reviews focusing 
on pharmacological properties of anesthetic agents (Dalal et al., 2014; Kelly et al., 2012; Nitsun 
et al., 2006; Shergill et al., 2012). Lack of robust studies with randomization, small sample size, 
and limited sample settings that predominate current literature challenges credibility and can 
undermine transferability of current literature. Additionally, gaps identified include lack of 
human data, specifically studies that detect the presence of many commonly used anesthetic 
agents in breast milk (e.g., ketamine, sevoflurane, remifentanil). Not found in the literature are 
studies that evaluate the transfer of drugs via breast milk to children that may reveal different 
pharmacodynamic profiles since there is an increased amount of breast milk consumption and 
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therefore drug ingestion in this population (Chu et al., 2013). Due to the fragility of premature 
and special needs infants, there is limited information in regards to recommendations for 
resumption of breastfeeding in this distinctive population.  
Current Literature  
The mechanism of transfer of most commonly used anesthetic drugs into breast milk is 
by passive diffusion and based on the physiochemical properties of the anesthetic agent. Those 
drugs that are highly protein bound, less lipid soluble, have a lower pKa and a larger molecular 
weight lack the ability to penetrate breast milk (Dalal et al., 2014). Drugs used during the 
perioperative period are classified into standard pharmacological categories of analgesic opioids, 
benzodiazepines, intravenous anesthetic agents, local anesthetics, neuromuscular blockers and 
reversal agents, volatile anesthetics, and antiemetics.  
Analgesic Opioids 
Judicious administration of analgesic opioids in the perioperative period is a requisite for 
anesthetic practice due to their risk of maternal and infant respiratory depression, hypercapnia, 
and hypoxemia. Discussion of commonly used opioids, their transfer into breast milk, and 
recommendations are below.  
Fentanyl. Favored for its short duration of action and fast onset, Fentanyl is one of the 
most commonly administered opioids utilized for analgesia during the perioperative period. 
Authors established that maternal administration of fentanyl in the perioperative period was 
unlikely to result in adverse outcomes for a healthy, term breastfeeding infant; there is no 
requirement for milk discarding or waiting for the resumption of breastfeeding (Nitsun et al., 
2006; Shergill et al., 2012).  
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Remifentanil. Remifentanil may be a promising perioperative opioid analgesic for 
breastfeeding mothers due to its unique pathway of metabolism in the serum, rapid onset and 
offset, lack of accumulation and rapid recovery after discontinuation (Flood et al., 2015). Four 
case studies presented by Stuttmann, Schafer, and Hilbert (2010) reported no adverse outcomes 
or signs of sedation in breastfed infants after maternal administration of remifentanil as part of 
their general anesthetic. However, remifentanil is an unsuitable option for the treatment of acute 
postoperative pain due to its brief context-sensitive half-life of less than 10 minutes. 
Morphine. Considered less potent when compared to fentanyl, morphine is a commonly 
used opioid in anesthetic practice favored for its longer duration of action and treatment of 
postoperative pain, reaching peak effect 90 minutes after intravenous administration (Flood et 
al., 2015). However, morphine is associated with a greater depression of ventilatory response to 
hypoxia in women. Metabolized to an active, more potent metabolite morphine-6-glucurcoids 
requires renal elimination (Flood et al., 2015). Morphine secretion in breast milk was studied in 
the literature over two decades ago. Earlier studies suggest that the amount of maternally 
transferred morphine to the breastfeeding infant is variable and warrants caution (Robieux et al., 
1990; Baka et al., 2002). Furthermore, infants under one month of age, exposed to morphine are 
at an increased risk of sedation and respiratory problems due to immature metabolization and 
clearance of the drug (Hale, 2017). The evidence suggests extreme caution or avoidance of 
morphine administration to the breastfeeding mother (Dalal et al., 2014). 
Other. Current literature suggests that perioperative administration of other analgesic 
opioids such as meperidine and hydromorphone are not agents of choice in lactating women as 
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there is an increased risk of respiratory depression for the breastfeeding infant (Dalal et al., 
2014).  
Benzodiazepines 
Midazolam is one of the most common benzodiazepines administered as part of a general 
anesthetic for its sedating and anxiolytic effects. Several authors suggest that midazolam, 
administered perioperatively, was not likely to affect a healthy, term infant, which supports the 
resumption of breastfeeding after surgery (Nitsun et al. 2006; Dalal et al. 2014). The use of 
perioperative diazepam or lorazepam is unsafe for the breastfeeding infant and should be 
avoided.  
Intravenous Anesthetic Agents 
General anesthesia requires the administration of intravenous anesthetic agents, which 
cause a reversible loss of consciousness. Commonly used intravenous anesthetic agents include 
propofol, ketamine, and etomidate. Due to their short duration of action and rapid metabolism 
with no active metabolite, propofol and etomidate are safe for administration in the breastfeeding 
mother with no waiting period necessary for the resumption of breastfeeding (Cobb et al., 2015). 
The combined administration of ketamine and propofol decreases postoperative pain and opioid 
consumption in breastfeeding mothers (Jaafarpour, Vasigh, Khajavikhan, & Khani, 2017). 
Research in the literature regarding maternal administration of ketamine and the subsequent 
exposure to the breastfeeding infant is nonexistent. Ketamine’s known short half-life, and rapid 
redistribution out of plasma suggests milk levels of ketamine would be low after maternal 
administration (Hale, 2017; LactMed®, 2017). Current recommendations for ketamine 
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administration in the breastfeeding mother are for the close monitoring of the infant post 
maternal administration.  
Local Anesthetics 
Local anesthetics physiochemical properties limit their ability to transfer into breast milk 
and furthermore are poorly absorbed by the breastfeeding infant (Chu et al., 2013; Cobb et al., 
2015). Authors established that intravenous, peripheral, or neuraxial administration of lidocaine 
results in minimal lidocaine concentrations in breast milk, does not precipitate adverse effects in 
the nursing infant, and decreases postoperative opioid requirements for nursing mothers (Chu et 
al., 2013; Cobb et al., 2015; Thawart et al., 2016). Neuraxial administration of lidocaine, 
bupivacaine, or ropivacaine is safe to use in lactating women, and no special precautions are 
required (Cobb et al., 2015; Dala et al., 2013).  
Neuromuscular Blockers and Reversal Agents 
General anesthesia often requires neuromuscular relaxation to facilitate ease of 
endotracheal intubation and a favorable surgical environment. Chemical properties inherent to 
neuromuscular blocking agents including, large molecular size, poor lipid solubility, and 
polarized nature, restrict their ability to diffuse into breast milk passively and are presumed safe 
for use in lactating women (Dala et al., 2014; Chu et al., 2013; Cobb et al., 2015). Besides, the 
rapid metabolization and poor oral bioavailability of commonly used neuromuscular blocking 
agents, succinylcholine, vecuronium, rocuronium, and cisatracurium, demonstrates the 
unlikelihood of these agents to reach breast milk in sufficient concentrations or reach the 
bloodstream of a breastfeeding infant (Dala et al., 2014). The combination of an 
acetylcholinesterase-inhibiting agent (neostigmine) and an anticholinergic agent (glycopyrrolate) 
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is administered to reverse neuromuscular relaxation. As quaternary ammonium compounds, the 
physiochemical properties of neostigmine and glycopyrrolate prevent their ability to penetrate 
the blood-milk barrier easily and are unlikely to affect the breastfed infant (Dala et al., 2014; 
Cobb et al., 2015; LactMed®, 2017). 
Inhaled Anesthetics 
There is no published data in regards to inhaled anesthetic levels measured in human 
milk. Inhaled anesthetics have poor bioavailability, rapidly eliminated once administration ceases 
via alveolar ventilation (Flood et al., 2015). Based on the available evidence and known 
pharmacokinetics of the elimination of inhaled anesthetics, absorption by the breastfeeding infant 
is likely nil and no discarding of milk or waiting period is required (Bhaskara et al., 2016; Dala 
et al., 2014; Reece-Stremtan, Campos, & Kokajko, 2017).  
Antiemetics 
Ondansetron and metoclopramide are commonly used agents for the prevention and 
treatment of postoperative nausea and vomiting. As well, these agents have been administered to 
lactating women for treatment of nausea after cesarean section (ondansetron) and as 
galactagogues (metoclopramide) (LactMed®, 2017). Ondansetron and metoclopramide readily 
cross the blood-milk barrier; however, no adverse infant effects have been reported and may be 
safely used in lactating women (Dala et al., 2014; Chu et al., 2013; Elkomy et al., 2015). 
ETHICAL CONSIDERATIONS 
Institutional Review Board (IRB) approval from the facility this project was implemented 
was obtained before implementation in the clinical setting. With the intent to demonstrate respect 
for all participants, the purpose of this project was explained and full disclosure of all parts of 
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this DNP project made available. Participant’s anonymity and confidentiality was maintained 
through utilization of the My AGREE PLUS platform. Explanation of the risks and benefits 
provided, emphasizing that, study outcomes would not result in judgment, criticism, or misuse 
(Polit & Beck, 2012). Described as a moral obligation to act in kindness and do well, the 
principal beneficence was demonstrated by treating all participants with kindness and respect. 
Project transparency in regards to project purpose and potential implications for future research 
was disclosed. All participants were treated judiciously, with no distinction made between 
participants based on personal characteristics, experience, competence, or merit. With the intent 
to demonstrate fairness and equality, all participants were given the opportunity to complete the 
same questionnaire; no questions were altered at any time. The project leader honored all 
agreements made with participants, respecting their personal choice to participate or not 
participate in this DNP project.  
METHODS 
Project Design 
Rogers’ Diffusion of Innovation Theory of Organizational Change was instrumental as a 
guide for this DNP project. The first two stages of organizational change were implemented with 
the development of a CPG and the dissemination of the evidence to key stakeholders.  
The working framework utilized for this DNP project was the Appraisal of Guidelines for 
Research and Evaluation (AGREE II) Instrument. The AGREE II provides a systematic strategy 
for the development of guidelines and serves as a tool to assess the quality, rigor, and 
transparency of the developed guideline. The AGREE II framework is a validated tool that meets 
all criteria outlined by the Institute of Medicine for the development and assessment of CPGs.  
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The first phase of this DNP project involved the systematic development of a CPG based 
on current evidence in the literature. Methods used for collection and selection of current 
evidence was previously discussed in this paper. The development of an evidence-based clinical 
guideline requires the author to identify and weigh the quality and strength of the evidence to 
support the recommendations. Levels of evidence supporting recommendations were based on 
the National Guideline Clearing House (Figure 2).  
 
FIGURE 2. Evidence hierarchy of designs. (Based on the National Guideline Clearing House adapted from 
Polit, D. F. & Beck, C. T. (2012). Nursing research. Generating and assessing evidence for nursing practice (9th 
ed.). Philadelphia, PA: Wolters Kluwer; Lippincott, Williams & Wilkins.) 
The second phase of this DNP project was accomplished by utilizing the Appraisal of 
Guidelines for Research and Evaluation II (AGREE II) framework. An interdisciplinary panel 
consisting of a pharmacist, two lactation specialists, and one anesthesia provider appraised the 
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newly developed CPG utilizing the AGREE II instrument. The AGREE II tool provided a guide 
for appraisers to assess the quality of the developed guideline via six domains and two global 
rating items to increase the reliability of the developed CPG.  
Setting and Participants 
The audience for this DNP project included anesthesia providers (n=11) at a mid-sized 
rural facility in Northern Arizona for which this CPG was developed. The interdisciplinary panel 
of critical appraisers (Figure 3) involved in assessing the quality of the CPG included one 
pharmacist, two lactation specialists, and one anesthesia provider licensed to practice in their 
respected fields in the state of Arizona. A multidisciplinary panel consisting of greater than four 
appraisers increases the reliability of the developed CPG assessment (Brouwers et al., 2010).  
 
FIGURE 3. Critical appraisers. 
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Data Collection 
Project data collection for the second phase of this project began after organizational and 
IRB of Northern Arizona University approval. The My AGREE PLUS platform was utilized to 
evaluate and assess the developed CPG by the interdisciplinary panel. The My AGREE PLUS 
platform is a free, online, electronic platform that allows appraisers to collaborate and evaluate a 
particular practice guideline using the AGREE II assessment tool (Brouwers et al., 2010). The 
AGREE II assessment tool (Appendix C) is comprised of 23 key items organized within six 
domains and two overall guideline assessments. These six domains: 1) scope and purpose; 2) 
stakeholder involvement; 3) rigor of development; 4) clarity of presentation; 5) applicability; 
and, 6) editorial independence assess the overall quality of the guidelines and its 
recommendation into practice (AGREE Next Steps Consortium, 2017). The two global guideline 
assessments: 1) rate the overall quality of this guideline, and 2) I would recommend this 
guideline for use required the AGREE II evaluator to determine if this CPG was a quality 
guideline to be implemented (AGREE Next Steps Consortium, 2017). 
Each AGREE II key items are rated on a Likert seven-point scale, from ‘1’ point 
representing strongly disagree to ‘7’ points representing strongly agree. The summated rating 
scale uniquely captures the dimensions of the developed CPG and shows clear discrimination of 
the guideline quality (AGREE Next Steps Consortium, 2017).  
To promote standardization of scoring, each panel member was required to sign a written 
statement (Appendix C) that confirms his or her completion of a brief online tutorial for the 
AGREE II assessment tool before assessment of the developed CPG. A welcome packet was 
provided for all appraisers that included; a welcome letter introducing the DNP project 
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(Appendix A), instructions on how to complete the online AGREE II assessment tutorial, and 
how to contact the project leader for any questions or concerns related to this DNP project. 
Appraisers were given a copy of the AGREE II assessment tool (Appendix B) and manual with a 
three-week window in which to complete the online tutorial and AGREE II assessment of the 
developed CPG.  
Data Analysis  
A quality score was calculated for each of the AGREE II six domains independently. The 
domain scores were calculated by summing up all scores of individual items in each domain and 
scaling the total as a percentage of the maximum possible score for that domain (AGREE Next 
Steps Consortium, 2017). A maximum possible score was calculated for each domain [7 
(strongly agree) x (domain items) x 4 (number of appraisers)]. Next, a minimum possible score 
was calculated for each domain [1 (strongly disagree) x (domain items) x 4 (number of 
appraisers)]. Last, the scaled individual domain scores were calculated [(Obtained score – 
Minimum possible score) / Maximum possible score – Minimum possible score)] x 100. The 
final score was reported in a percentage for each domain. 
RESULTS 
The AGREE II online guideline appraisal provided individual scores for all 23 questions 
along with the opportunity for appraisers to add personal comments for all items. A cumulative 
score for each of the six domains resulted with a final overall guideline assessment rating the 
quality of the developed guideline. The Seven-Point Agree II Score Calculator and Decision 
Rules were utilized to calculate the combined score of all appraisers and determine guideline 
quality. The detailed results of the appraisal can be found in table format (Figure 4). A quality 
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threshold of all domain scores higher than 80% indicates a high-quality guideline. A quality 
threshold of greater than 80% was assigned to each domain meaning that no revisions are 
needed.  
The overall quality (OA1) of the developed guideline was assessed and resulted in a 
combined score of 92%, representative of a high-quality guideline. Demonstrating low 
discrepancy between appraisers, the standard deviations for all domains were less than 0.5%. The 
overall combined score of the six domains were 96%, 88%, 89%, 97%, 97%, and 100% (Figure 
4) respectively, indicating that no action is necessary to revise the developed CPG. Appraisers 
overall judgment concerning recommended use of the developed guideline resulted with an 
answer of ‘Yes,’ to the recommended use of the guideline. 
 
FIGURE 4. Agree II total domain scores. (Greater than 80%=no revisions needed and high-quality 
guideline. OA1=overall quality.) 
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Based on the calculated scores and the appraiser's comments, the developed guideline 
meets the criteria of a high-quality clinical practice guideline. Although no action is required to 
revise the guideline based on the calculated scores, the opportunity for appraisers to provide 
individual comments for each of the 23 questions aided in identifying strengths and weakness of 
the developed CPG. Comments and recommendations given by appraisers are to be addressed, to 
ensure the quality and ultimate adoption of the developed guideline by stakeholders.  
Appraiser Comments 
An advantage to the AGREE II online appraisal tool is the ability for appraisers to 
comment within each domain appraised. Constructive comments to enhance the overall quality 
of the developed CPG are listed below.  
Domain 1 
Scope and Purpose Item 2 Appraiser 2: it could have been more advantageous to clearly 
identify the question.  
Domain 2 
Stakeholder Involvement Item 4 Appraiser 6: It would have been beneficial to add a 
Gynecologist within the interdisciplinary team. The guideline should also include the 
postoperative RN who provides the majority of patient education. 
The respondent’s comments enable the project leader to see clear discrimination of 
appraiser’s views and concerns regarding the developed CPG. Ensuring clear identification of 
the health question will provide ease of understanding and clarity for users of the developed CPG 
and serve to increase usability. Including postoperative registered nurses as well as women’s 
   
30 
health providers in the interdisciplinary team aids in validating transferability and adoption of the 
developed CPG.  
DISCUSSION 
Strengths  
The ability for appraisers to score each domain nominally as well as to add free text 
comments provided valuable information and insight on the quality of the CPG. An 
interdisciplinary appraisal team of greater than four member’s increases CPG transferability and 
reliability of data collected. The CPG was developed to reduce the ambiguity of advice imparted 
to breastfeeding mothers who require general anesthesia. To promote the relay of consistent, 
current evidence-based information to the breastfeeding mother serves to reduce anxiety in this 
population and improve outcomes. This DNP project addresses the identified gap in clinical 
practice and provides a systematically developed high-quality guideline to assist anesthesia 
providers and their patients about appropriate decisions in regards to the resumption of 
breastfeeding after general anesthesia.  
Limitations 
The body of evidence presented in this CPG was accumulated, appraised, and developed 
into a clinical practice guideline by one person for the purpose of a DNP project. In the setting of 
DNP scholarly work, the AGREE II tool was utilized as a framework in which to evaluate the 
developed DNP academic work. The AGREE II tool does not allow for an appraiser to choose a 
“Not Applicable” response in the setting of an AGREE II item that may not be applicable. This 
may be reflected in the score for Domain 2 Stakeholder involvement, which received a score of 
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89%. In Domain 2, appraisers were asked to evaluate the stakeholder involvement in the 
development of the CPG which was not applicable in this setting. 
Interpretation of CPG quality based on domain scores is ambiguous, as there is no 
empirical data to link specific quality scores with implementation outcomes (Brouwers et al., 
2010). An approach to aid in the interpretation of domain scores is to assign quality thresholds 
before beginning the AGREE II appraisal.  
Recommendations for Practice  
There is objective evidence and extensive research concerning drug chemistry and factors 
that influence maternal drug transfer into breastmilk and subsequent infant exposure to said 
drugs. The mechanism of transfer of most commonly used anesthetic drugs into breastmilk is by 
passive diffusion and based on the physiochemical properties of the anesthetic agent. Those 
drugs that are highly protein bound, less lipid soluble, have a lower pKa and a larger molecular 
weight lack the ability to penetrate breastmilk (Dalal et al., 2014). The overwhelming evidence 
suggests that drugs administered to a breastfeeding mother during the perioperative period will 
not precipitate adverse outcomes in the healthy breastfed infants (Dalal, Bosak, & Berlin, 2014). 
A breastfeeding mothers return to baseline mentation and strength, suggest drug 
redistribution from plasma and milk, and termination of drug action (Cobb et al., 2015). 
Furthermore, there is no required waiting period or discarding of milk necessary before the 
resumption of breastfeeding once a mother has recovered from general anesthesia (Chu et al., 
2013; Dalal et al. 2014; Kelly et al., 2012; Shergill et al., 2012). In most cases, general anesthesia 
is administered for a short period utilizing a combination of anesthetic agents. Several authors 
suggest that, in general, when administering a combination of anesthetic agents, follow the 
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recommendations for the most problematic medication used during the procedure and caution is 
advised for anesthetic agents with prolonged half-lives and potent metabolites that may lead to 
drug accumulation (LactMed®, 2017; Sachs, 2013; Shergill et al., 2012). 
Dissemination of this project was accomplished via an electronic presentation at an 
anesthesia staff meeting at the Northern Arizona facility. Presently, there is no published CPG 
that addresses resumption of breastfeeding after general anesthesia. This scholarly DNP project 
aimed to open the discussion and provide education to anesthesia providers concerning 
breastfeeding and general anesthesia to aid in the relay of current and evidence-based advice for 
when to resume breastfeeding after general anesthesia. 
The adoption of the developed CPG resulted in positive patient outcomes and decrease 
ambiguity in advice provided to breastfeeding mothers who require general anesthesia. It served 
to enhance the anesthesia provider’s perioperative management plan and promoted an 
appropriate and safe post-operative patient care plan. 
Adoption of this CPG should be evaluated via a focus group assessment during the first 
three months of implementation to determine if anesthesia providers are utilizing the developed 
CPG and identify barriers to adoption if they arise. A procedure for monitoring and updating the 
guideline should be planned to ensure that the guideline is updated with current evidence when 
applicable. A CPG is only sustainable if there is a continual study of evolving evidence and 
modernization of recommendations based on arising evidence. 
The Dissemination Plan  
Essential to sustainable practice change and the development of future practice, 
scholarship is the dissemination of knowledge gained in this DNP project. Upon completion of 
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this DNP project, findings were shared with the Northern Arizona facility during a scheduled 
meeting for anesthesia providers. The project leader presented the project in a digital PowerPoint 
presentation with handouts engaging key stakeholders. The presentation was followed by an 
open discussion where audience members commented that the developed CPG filled a gap in 
clinical practice. The presentation and developed CPG was praised and accepted for facility 
adoption. At follow-up evaluation, the Chief of Anesthesia stated: “since the presentation, we 
have had several breastfeeding mothers, and all anesthesia providers have adopted the new 
guideline.” This project will also be disseminated at the Arizona Association of Nurse 
Anesthetists 2019 Fun and Sun Conference and the New Mexico Association of Nurse 
Anesthetist Nurse Anesthesia Conference 2019.  
DNP ESSENTIALS 
This DNP project incorporated two significant elements of the DNP Essentials. 
DNP Essential III 
Clinical Scholarship and Analytical Methods for Evidence-Based Practice. Integration of 
knowledge from diverse sources across disciplines for the improvement of health outcomes is 
demonstrated in this scholarly project and fulfills this essential. Critically appraising the existing 
evidence and facilitating its translation into clinical practice as evidenced by the synthesis of 
evidence validates competency of this essential. 
DNP Essential VI 
Interprofessional Collaboration for Improving Patient and Population Outcomes is 
represented in this project through the facilitation of an effective interprofessional team and 
demonstrates this project leader's ability to be an effective team leader. 
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CONCLUSION 
The developed CPG provides anesthesia providers with a synthesis of research findings 
and strong, evidence-based recommendations regarding the resumption of breastfeeding after 
general anesthesia. Translation of research into clinical practice remains to be a challenge in 
healthcare; however, the developed CPG serves to bridge the gap between research and clinical 
practice to improve patient outcomes in this unique population. Future implications include 
dissemination of the developed CPG to ancillary staff including registered nurses and lactation 
specialists that work closely with breastfeeding mothers. To continue to improve and strengthen 
the CPG, women’s health care providers; obstetrician, midwives, and gynecologists, as well as 
registered nurses, should be a part of the interdisciplinary team. 
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PARTICIPANT WELCOME LETTER 
 
   
36 
Dear Provider,  
 
My name is Lacey Gibson, and I am a nurse currently perusing my doctorate in Nurse 
Anesthesia at the University Of Arizona. I am writing to invite you to participate in my DNP 
project about breastfeeding after anesthesia. The purpose of this DNP project is to develop a 
clinical practice guideline (CPG) for the resumption of breastfeeding after general anesthesia. 
You are being asked to participate in this project because you currently work in a relevant health 
profession and are considered a key stakeholder for the planned, developed clinical practice 
guideline. 
 
Participation in the study entails completing the AGREE II Overview Tutorial which can be 
found at http://www.agreetrust.org/resource-centre/agree-ii-training-tools// and then appraising 
the developed CPG utilizing the AGREE II assessment tool. An email will be sent directly from 
the My AGREE Plus platform with directions and links to complete the online CPG appraisal.  
 
Completing the online CPG appraisal and participating in this project is entirely voluntary, and 
implies informed consent. If you decide to participate in this study, all data collected will remain 
confidential and anonymous. Information gathered through this project will be used for this DNP 
project and may be used for the development of future scholarly projects. At this time, the author 
has no plans to publish the information gathered from this study. This study was reviewed and 
found to be acceptable by the Institutional Review Board responsible for human subjects at 
Northern Arizona University, which serves to protect the rights and welfare of participants in 
research under university policies, state, and federal regulations. Participation in the study does 
not revoke the legal right you have as a participant.  
 
Your choice to participate in this study is entirely voluntary with no known risks. You may 
choose to decline or stop participation at any time during the study. Your decision to refuse or 
stop participation will be respected and will not affect any future relationship with the University 
of Arizona or affiliated organization.  
 
For questions, concerns, or complaints related to this study, please feel free to contact the 
researcher, Lacey Gibson at laceygibson@email.arizona.edu or (602) 315-8661. As well, if you 
have questions or concerns regarding your rights as a participant in this study or to discuss study-
related concerns you are encouraged to contact the Human Subjects Protection Program at your 
facility.  
 
Thank you for your time and consideration in supporting my DNP project.  
 
Lacey Gibson, BSN, RN, SRNA-DNP  
laceygibson@email.arizona.edu 
(602) 315-8661 
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AGREE II ASSESSMENT TOOL 
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AGREE II ASSESSMENT TOOL  
Domain 1. Scope and Purpose  1  
SD  
2 3 4 5 6 7 
SA 
1 The overall objective (s) of the guideline is (are) specifically described.        
2 The health question (s) covered by the guideline is (are) specifically described.        
3 The population to whom the guideline is meant to apply is specifically described.         
Domain 2. Stakeholder Involvement  1  
SD  
2 3 4 5 6 7 
SA 
4 The guideline development group includes individuals from all relevant professional groups.        
5 The views and preferences of the target population have been sought.        
6 The target users of the guideline are clearly defined.        
Domain 3. Rigor of Development  1  
SD  
2 3 4 5 6 7 
SA 
7 Systematic methods were used to search for evidence.        
8 The criteria for selecting the evidence are clearly described.        
9 The strengths and limitations of the body of evidence are clearly described.        
10 The methods for formulating the recommendations are clearly described.        
11 The health benefits, side effects, and risks have been considered in formulating the recommendations.         
12 There is an explicit link between the recommendations and the supporting evidence.        
13 The guideline has been externally reviewed by experts before its publication.        
14 A procedure for updating the guideline is provided.         
Domain. Clarity of Presentation  1  
SD  
2 3 4 5 6 7 
SA 
15 The recommendations are specific and unambiguous.        
16 The different options for management of the condition or health issue are clearly presented.         
17 Key recommendations are easily identifiable.         
Domain 5. Applicability  1  
SD 
2 3 4 5 6 7 
SA 
18 The guideline describes facilitators and barriers to its application.         
19 The guideline provides advice and/or tools on how the recommendations can be put into practice.         
20 The potential resource implications of applying the recommendations have been considered.         
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21 The guideline presents monitoring and/ or auditing criteria.         
Domain 6. Editorial Independence  1  
SD  
2 3 4 5 6 7 
SA 
22 The views of the funding body have not influenced the content of the guideline.        
23 Competing interests of guideline development group’s members have been recorded and addressed.         
SD (strongly disagree) SA (strongly agree) 
Overall Guideline Assessment  
For each question, please choose the response which best characterized the guideline assessed 
 1  
Lowest quality  
2 3 4 5 6 7 
Highest quality  
1 Rate the overall quality of this guideline         
 YES  YES, with modifications  NO  
2 I would recommend this guideline for use     
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AGREE II TUTORIAL COMPLETION AFFIDAVIT 
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This letter serves to confirm that I, ________________________________________________ 
have been provided a copy of the AGREE II assessment tool and user manual. That I have 
completed the AGREE II assessment tool online tutorial and been provided access to the 
AGREE II practice exercise in preparation for completing a formal appraisal of the developed 
Clinical Practice Guideline for Breastfeeding after Anesthesia.  
 
 
 
                 
Signature             Date 
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APPENDIX D: 
CLINICAL PRACTICE GUIDELINE:  
BREASTFEEDING AFTER GENERAL ANESTHESIA 
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Clinical Practice Guideline: 
breastfeeding after general anesthesia  
 
Introduction  
 
Inconsistent and often conflicting post-anesthetic advice imparted to breastfeeding mothers 
leads to unnecessary weaning or premature abandonment of nursing. The advice in regards to 
the resumption of breastfeeding and milk discards vary depending on anesthesia provider 
opinion, medical facility protocol, or the favored medically endorsed guideline. Furthermore, 
anesthesia providers, hospitals, and patients may rely on conservative and often restrictive 
recommendations given by drug manufacturers that do not accurately reflect conditions for 
lactating women and the transfer of anesthesia and analgesia medications into breast milk 
(Cobb, Liu, Valentine, & Onuoha, 2015). 
 
Lack of clarity and inconsistent recommendations places unnecessary stress on this 
population and is a barrier for breastfeeding mothers. Mothers who require anesthesia may 
abandon nursing based on overly conservative and outdated advice from their anesthesia 
providers leading to unfortunate outcomes for both mother and baby. For these reasons, this 
CPG sets out to identify evidenced-based research regarding post-anesthetic advice to be 
imparted to breastfeeding mothers.  
 
Scope and purpose  
 
Guideline objective  
This CPG intends to furnish breastfeeding mothers and their anesthesia providers with 
evidence-based recommendations for the resumption of breastfeeding after general 
anesthesia. Updating current practice will result in consistent information relayed to the 
breastfeeding mother, serving to remove a barrier to breastfeeding and improve maternal and 
infant health outcomes. 
Target population  
 Breastfeeding mothers who require anesthesia, breastfeeding infants.  
 
Note: This guideline is a clinical guideline for the resumption of breastfeeding after general 
anesthesia, outside the postpartum period.  
 
Stakeholder involvement  
 
The guideline was developed by an interdisciplinary team consisting of stakeholders that 
represent the intended users of the guideline, anesthesia provider, lactation consultant, and 
pharmacist.  
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Mythology  
Methods used to collect/ select evidence 
A search of electronic databases 
 
Description of Methods Used  
A literature review was undertaken to identify current evidence in regards to anesthetic drug 
transfer via breastmilk and recommendations for breastfeeding mothers who require 
anesthesia. The following online literature archive databases were used, PubMed, 
Cumulative Index to Nursing and Allied Health Literature (CINAHAL), and Excerpta 
Medical database (EMBASE). Key terms used in the search included breastfeeding, general 
anesthesia, anesthetic agents, analgesic agents, infant drug exposure, breastmilk transfer, and 
medication. Additional inclusion criteria included articles published after 2013; English 
language, human subjects, and randomized clinical research studies. The outcome was fifteen 
articles, with all studies focused on labor-related analgesia and anesthesia. Broadening 
inclusion criteria to articles published in the last ten years and non-randomized clinical 
research resulted in thirty-three articles. 
 
Ethical constraints and difficulty recruiting nursing mothers and infants for controlled studies 
limit current research information. A large portion of literature about this topic did not 
qualify for inclusion based on publishing dates greater than ten years. Therefore, a literature 
search for commonly used anesthetic drugs and their transfer into breastmilk was conducted. 
The peer-reviewed database provided by the National Institute of Health (NIH) LactMed® 
was utilized for the additional literature search. Drugs and other chemicals to which 
breastfeeding mothers may be exposed to, as well as levels of such substances found in 
breastmilk and possible adverse effects in the nursing infant, is reviewed from scientific 
literature, validated, and provided by LactMed®. (LactMed®, 2017). 
 
Number of Source Documents  
Ten articles from the literature met the rigor of this review, based on their relevancy, validity, 
and reliability. All articles were published after 2012. 
 
Methods used to assess the quality and strength of evidence.  
 
A 7-level hierarchy presented by Polit & Beck was utilized to assign a level of evidence 
based on the strength and quality of evidence provided (2012). The grade of recommendation 
was assigned utilizing Strength of Recommendation Taxonomy (SORT) developed by the 
editors of the U.S. family of medicine and primary care journals (Ebell et al., 2004). 
 
The use of two rating scales accommodates for the strength of evidence based on evidence 
source and the context of the clinical practice setting that the recommendation will be applied 
(Dicenso et al., 2005). Evidence retrieved included one randomized control trial (Level IIa), 
cohort studies and non-randomized control trials (Level IIIa), and observational and case 
studies (Level IVa). Levels of evidence, based on the source of evidence, was fair in respect 
to a lack of randomized control trials related to a preponderance of benefit over harm. 
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Rating scheme for the strength of evidence  
  
Level of Evidence  
   
Strength of Evidence 
 
 
Description of Methods of Guideline Validation  
 
The final draft of the developed CPG underwent extensive external review by an 
interdisciplinary panel representing the specialties of anesthesia, pharmacy, and lactation. 
The My AGREE PLUS platform was utilized which provides a summated rating score that 
uniquely captures dimensions of the developed CPG and shows clear discrimination of the 
guideline quality.  
 
Recommendations  
 
General statement  
There is objective evidence and extensive research concerning drug chemistry and factors 
that influence maternal drug transfer into breastmilk and subsequent infant exposure to said 
drugs. The overwhelming evidence suggests that drugs administered to a breastfeeding 
mother during the perioperative period will not precipitate adverse outcomes in the healthy 
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breastfed infants (Dalal, P., Bosak, J. & Berlin, C., 2014). A breastfeeding mothers return to 
baseline mentation and strength, suggest drug redistribution from plasma and milk, and 
termination of drug action (Cobb et al., 2015). Furthermore, there is no required waiting 
period or discarding of milk necessary before the resumption of breastfeeding once a mother 
has recovered from general anesthesia (Chu et al., 2013, Dalal et al. 2014, Kelly et al., 2012, 
Shergill et al., 2012). In most cases, general anesthesia is administered for a short period 
utilizing a combination of anesthetic agents. Several authors suggest that, in general, when 
administering a combination of anesthetic agents, follow the recommendations for the most 
problematic medication used during the procedure and caution is advised for anesthetic 
agents with prolonged half-lives and potent metabolites that may lead to drug accumulation 
(LactMed®, 2017, Sachs, 2013, Shergill et al., 2012).  
 
The American Academy of Pediatrics Committee on Drugs surmises, “The benefits of 
breastfeeding outweigh the risk of exposure of most therapeutic agents via breastmilk” 
(Sachs, 2013, p. 805).  
 
Standard anesthetic agents and Recommendations  
The mechanism of transfer of most commonly used anesthetic drugs into breastmilk is by 
passive diffusion and based on the physiochemical properties of the anesthetic agent. Those 
drugs that are highly protein bound, less lipid soluble, have a lower pKa and a larger 
molecular weight lack the ability to penetrate breastmilk (Dalal et al., 2014). Drugs during 
the perioperative period can be classified into standard pharmacological categories of 
analgesic opioids, benzodiazepines, intravenous anesthetic agents, local anesthetics, 
neuromuscular blockers and reversal agents, and volatile anesthetic.  
 
Analgesic opioids. Judicious administration of analgesic opioids in the perioperative period 
is a requisite for anesthetic practice due to their risk of maternal and infant respiratory 
depression, hypercapnia, and hypoxemia. Discussion of commonly used opioids, their 
transfer into breastmilk, and recommendations are below.  
Fentanyl. Favored for its short duration of action and fast onset, Fentanyl is one of 
the most commonly administered opioids utilized for analgesia during the 
perioperative period. Authors established that maternal administration of fentanyl in 
the perioperative period was unlikely to result in adverse outcomes for a healthy, term 
breastfeeding infant and no requirement for milk discarding or waiting for the 
resumption of breastfeeding is required (Nitsun et al., 2006, Shergill et al., 2012).  
Remifentanil. Remifentanil may be a promising perioperative opioid analgesic for 
breastfeeding mothers due to its unique pathway of metabolism in the serum, rapid 
onset and offset, lack of accumulation and rapid recovery after discontinuation of its 
administration (Flood et al., 2015). Four case studies presented by Stuttmann, 
Schafer, & Hilbert (2010) reported no adverse outcomes or signs of sedation in 
breastfeed infants after maternal administration of remifentanil as part of their general 
anesthetic. However, remifentanil is an unsuitable option for the treatment of acute 
postoperative pain due to its brief context-sensitive half-life of less than 10 minutes.  
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Morphine. Considered less potent when compared to Fentanyl, Morphine is a 
commonly used opioid in anesthetic practice favored for its longer duration of action 
and treatment of postoperative pain reaching peak effect 90 minutes after intravenous 
administration (Flood et al., 2015). However, morphine is associated with a greater 
depression of ventilatory response to hypoxia in women. Metabolized to an active, 
more potent metabolite Morphine-6-glucurcoids requires renal elimination (Flood et 
al., 2015). Morphine secretion in breastmilk was studied in the literature over two 
decades ago. Earlier studies suggest that the amount of maternally transferred 
morphine to the breastfeeding infant is variable and warrants caution (Robieux et al., 
1990, Baka et al., 2002). Furthermore, infants under one month of age, exposed to 
morphine are at an increased risk of sedation and respiratory problems due to 
immature metabolization and clearance of the drug (Hale, 2017). Evidence suggests 
that morphine administration to the breastfeeding mother should be avoided or used 
with extreme caution with the close infant and maternal monitoring (Dalal et al., 
2014).  
Other. Current literature suggests that perioperative administration of other analgesic 
opioids such as meperidine and hydromorphone are not of the agents of choice in 
lactating women as there is an increased risk of respiratory depression for the 
breastfeeding infant (Dalal et al., 2014).  
 
Benzodiazepines. Midazolam is one of the most common benzodiazepines administered as 
part of a general anesthetic for its sedating and anxiolytic effects. Several authors suggest 
that midazolam administered perioperatively was not likely to affect a healthy, term infant 
which supports the resumption of breastfeeding after surgery (Nitsun et al. 2006, Dalal et al. 
2014). The use of perioperative diazepam or lorazepam is considered unsafe for the 
breastfeeding infant and should be avoided.  
 
Intravenous anesthetic agents. General anesthesia is induced by administration of 
intravenous anesthetic agents, which cause a reversible loss of consciousness. Commonly 
used intravenous anesthetic agents include propofol, ketamine, & etomidate. Due to their 
short duration of action and rapid metabolism with no active metabolite, propofol and 
etomidate are considered safe for administration in the breastfeeding mother with no waiting 
period necessary for the resumption of breastfeeding (Cobb et al., 2015). The combined 
administration of ketamine & propofol has been shown to decrease postoperative pain and 
opioid consumption in breastfeeding mothers (Jaafarpour, Vasigh, Khajavikhan, & Khani, 
2017). Research literature regarding ketamine is not existent. Ketamine's short half-life and 
rapid redistribution out of plasma suggest milk levels of ketamine would be low after 
maternal administration (Hale, 2017, LactMed®, 2017). Current recommendations include 
close infant monitoring after maternal administration. 
 
Local anesthetics. Local anesthetics physiochemical properties limit their ability to transfer 
into breastmilk and furthermore are poorly absorbed by the breastfeeding infant (Chu et al., 
2013, Cobb et al., 2015). Authors established that intravenous, peripheral, or neuraxial 
administration of lidocaine results in minimal lidocaine concentrations in breastmilk, is not 
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expected to cause adverse effects in the nursing infant, and reduces postoperative opioid 
requirements for nursing mothers (Chu et al., 2013, Cobb et al., 2015, Thawart et al., 2016). 
Neuraxial administration of lidocaine, bupivacaine, or ropivacaine is safe to use in lactating 
women, and no special precautions are required (Cobb et al., 2015, Dala et al., 2013). 
 
Neuromuscular blockers and reversal agents. General anesthesia often requires 
neuromuscular relaxation to facilitate ease of endotracheal intubation and a favorable 
surgical environment. Chemical properties inherent to neuromuscular blocking agents; large 
molecular size, poor lipid solubility, and polarized nature restrict their ability of passively 
diffuse into breastmilk and are presumed safe for use in lactating women (Dala et al., 2014, 
Chu et al., 2013, Cobb et al., 2015). Also, the rapid metabolization and poor oral 
bioavailability of commonly used neuromuscular blocking agents; succinylcholine, 
vecuronium, rocuronium, and cisatracurium, demonstrates the unlikelihood of these agents to 
reach breastmilk in sufficient concentrations or reach the bloodstream of a breastfeeding 
infant (Dala et al., 2014). The combination of an acetylcholinesterase-inhibiting agent 
(neostigmine) and an anticholinergic agent (glycopyrrolate) is often given to reverse 
neuromuscular relaxation. As quaternary ammonium compounds, glycopyrrolate and 
neostigmine, physiochemical properties prevent their ability to penetrate the blood-milk 
barrier easily and are unlikely to affect the breastfed infant (Dala et al., 2014, Cobb et al., 
2015, LactMed®, 2017)  
 
Inhaled anesthetics. There is no published data in regards to inhaled anesthetic levels 
measured in human milk. Inhaled anesthetics have poor bioavailability and are rapidly 
eliminated once administration ceases via alveolar ventilation (Flood et al., 2015). Based on 
the available evidence and known pharmacokinetics of the elimination of inhaled anesthetics, 
absorption by the breastfeeding infant is likely nil and no discarding of milk or waiting 
period is required (Bhaskara et al., 2016, Dala et al., 2014, Reece-Stremtan, Campos, & 
Kokajko, 2017).  
 
Antiemetics. Ondansetron and metoclopramide are commonly used agents for the prevention 
and treatment of postoperative nausea and vomiting. As well, these agents have been used in 
lactating women for treatment of nausea after cesarean section (ondansetron) and as 
galactagogues (metoclopramide) (LactMed®, 2017). Ondansetron and metoclopramide 
readily cross the blood-milk barrier, no adverse infant effects have been reported and may be 
safely used in lactating women (Dala et al., 2014, Chu et al., 2013, Elkomy et al., 2015).  
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Anesthesia resource 
 
 
 
Implications for clinical practice and research  
 
Limitations identified in the literature search was a narrow pool of current high-level 
research studies, finding that most notable and established studies concerning breastfeeding 
and anesthetic agents were published over a decade earlier. Do to ethical constraints and the 
considerably small population of breastfeeding mothers who require general anesthesia; there 
is a scarcity of large or robust studies in this population. Current scientific literature is limited 
to observational studies, retrospective cohort studies, case studies, and literature reviews 
focusing on pharmacological properties of anesthetic agents (Dalal et al., 2014, Kelly et al., 
2012, Nitsun et al., 2006, & Shergill et al., 2012).  
 
Lack of robust studies with randomization, small sample size, and limited sample settings 
that predominate current literature challenges credibility and can undermine transferability of 
current research. Additionally, gaps identified include lack of human data, specifically 
studies that detect the presence of many commonly used anesthetic agents in breastmilk (e.g., 
ketamine, sevoflurane, remifentanil). Not found in the literature are studies that evaluate the 
transfer of drugs via breastmilk to children that may reveal different pharmacodynamic 
profiles since there is an increased amount of breastmilk consumption and therefore drug 
ingestion in this population (Chu et al., 2013). Due to the fragility of premature and special 
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needs infants, there is limited information in regards to recommendations for resumption of 
breastfeeding in this distinctive population. 
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51 
APPENDIX E: 
SYNTHESIS OF EVIDENCE 
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Author (Year)  Research Question 
Study 
Design/Framework 
Sample and 
Setting 
Data Collection 
(Instruments/tools) 
Findings 
Dozier, A., Howard, C., 
Brownell, E., Wissler, 
R., Glantz, J., Ternullo, 
S, & Lawrence, R. 
(2013) 
A potential association 
between intrapartum 
epidural anesthesia use 
and overall breastfeeding 
cessation within one 
month postpartum 
Mixed methods: 
retrospective chart 
review, bivariate 
retrospective chart 
review  
Sample: 727 healthy 
mothers (>18 y/o age) 
from 2 cohorts w/ 
healthy term singleton 
vaginal delivers who 
had initiated 
breastfeeding  
 
Setting: Three 
community hospitals in 
upstate New York  
Medical record data 
abstracted from EHR & 
maternal self-report via 
survey @ 2-weeks & 3-
months postpartum.  
Epidural anesthesia 
significantly 
predicted 
breastfeeding 
cessation (hazard 
ratio 1.26 [95 % 
confidence interval 
1.10, 1.44], 
p < 0.01)  
 
Low income, less 
education, and no 
breastfeeding goal 
predicted early 
cessation 
 
Dalal, P., Bosak, J. & 
Berlin, C. (2014) 
Safety of anesthesia-
related drugs in lactating 
women and their 
potential effects on the 
breastfed infant. 
Literature review  A search of available 
literature was 
conducted using the 
PubMed database from 
the National Library of 
Medicine, and LactMed 
Website.  
 
Researched commonly 
used drugs used in the 
perioperative period: 
anesthetic drugs,  
Reviewed articles were 
graded based on the Levels 
of Evidence (LOE) and the 
strength of 
recommendation 
(SOR) grading followed by 
the Oxford Center for 
Evidence 
Based medicine. 
Adverse drug 
reactions in 
breastfed infants 
following maternal 
drug exposure are 
rare; most being 
minor incidents and 
notably in infants 
<2 months of age.  
 
Drugs are 
transferred into 
breastmilk, the 
amount transferred 
is clinically 
insignificant and 
poses minimal to no 
risk to the nursing 
infant.  
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Author (Year)  Research Question 
Study 
Design/Framework 
Sample and 
Setting 
Data Collection 
(Instruments/tools) 
Findings 
Kelly, L., Poon, S., 
Madadi, P., & Koren, G. 
(2012) 
Assess CNS depression 
and other adverse effects 
in infants exposed to 
benzodiazepines through 
breastmilk.  
Prospectively recruited, 
retrospectively assessed 
cohort study of mothers  
One hundred twenty-
four self-referred 
mothers who contacted 
a local hospital in 
Toronto, Ontario 
between January 2010 
& May 2011 for advice 
regarding the use of 
benzodiazepines during 
lactation. 
 
Inclusion criteria:  
Fluent English 
speaking  
Used Benzodiazepines 
during breastfeeding.  
 
Breastfeeding follow-up 
form via telephone 
interview.  
 
Intake forms included:  
Medication used 
Frequency of breastfeeding  
Health of infants 
Demographic characterizes  
 
Categorical data for infant 
obtained during follow up 
included: Maternal & 
infant health concerns, 
evidence of neonatal CNS 
depression, breastfeeding 
frequency.  
 
Significance critical value 
of P < 0.5 was set  
 
Sedation was 
identified in 1.6 % 
of infants, and was 
not associated w/ 
benzodiazepine 
dose, the number of 
hours breastfeeding 
or taking 
concomitant CNS 
depressants. 
 
Conclusion: 
Supports the 
continued 
breastfeeding while 
taking 
benzodiazepines 
post-partum.  
Nitsun, M., Szokol, J., 
Saleh, H., Murphy, G., 
Vender, J., Luong, L., & 
Avram, M. (2006) 
Determine the 
pharmacokinetics of 
midazolam, Propofol, & 
fentanyl transfer into 
milk.  
Quasi-experimental 
observational study  
Five lactating women 
who required general 
anesthesia 
 
Premedicated w/ 
midazolam before 
induction of anesthesia. 
 
Maintenance of 
anesthesia w/ potent 
volatile anesthetic  
 
Milk & blood collected 
before drug administration. 
 
Milk collected 5, 7, 9, 11, 
& 24 hours after drug 
administration.  
 
Venous blood was 
collected at intervals up to 
7 hours post drug 
administration. 
 
Plasma & mild midazolam, 
Propofol, & fentanyl 
concentrations measured 
24 hour milk 
collection averages:  
•Midazolam: 0.005 
% of maternal dose.  
•Propofol: 0.027 % 
of maternal dose.  
•Fentanyl: 0.033 % 
of maternal dose  
 
Conclusion: The 
amount of drug 
excreted into milk 
w/ in 24 hours of 
induction of 
anesthesia is not 
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Author (Year)  Research Question 
Study 
Design/Framework 
Sample and 
Setting 
Data Collection 
(Instruments/tools) 
Findings 
by HPLC w/ tandem mass 
spectrometry & florescence 
detection.  
sufficient enough to 
justify the 
interruption of 
breastfeeding.  
 
Bhaskara, B., 
Dayananda, V., Kannan, 
S., Rao, R. R., & 
Ramachandraiah, R. 
(2016) 
Assess the effects of 
breastfeeding on the 
consumption of Propofol, 
sevoflurane, and 
hemodynamic stability in 
women  
A single-blind, 
prospective study 
 
One hundred twenty 
women scheduled for 
tubectomy under GA. 
 
Demographics:  
ASA class I & II 
Ages 20-30 y/o  
Uncomplicated 
pregnancy 
Delivered full-term 
healthy infants by 
vaginal route.  
 
Random allocation of 
study participants into 
three groups (40 in 
each group) 
(1) Breastfeeding (BF) 
(2) Withhold feeding 
(WF)  
(3) Non-feeding (NF) 
group.  
 
HR, MAP, and state 
entropy (SE) values 
recorded @ regular 
intervals.  
 
All participates received 
induction w/ propofol, 
maintenance of anesthesia 
w/ sevoflurane, in 60% 
N2O & O2 mixture.  
 
Analysis of variance & 
Chi-square test utilized for 
analysis of results  
BF group 
demonstrated:  
Reduces 
consumption of 
propofol by 20% & 
reduced 
consumption of 
sevoflurane by 35 % 
(p<0.05) when 
compared to NF 
group.  
 
Persistently low HR 
& MAP compared to 
WF group (P < 0.05)  
 
Conclusion: BF 
before induction of 
anesthesia decreases 
consumption of 
sevoflurane & 
propofol, and 
preserves 
hemodynamic 
stability.  
 
 
Shergill, A., Ben-
Menachem, T., 
Chandrasekhara, V., 
Chathadi, K., Decker, 
Guideline for educational 
purposes to provide 
information that will 
assist endoscopists in 
Clinical Guideline  Updated guideline 
utilizing PubMed for a 
search of medical 
literature. Additional 
Reviewed articles are 
graded on the strength of 
the supporting evidence. 
The power of individual 
Midazolam – 
recommendation to 
withhold nursing of 
the infant for @ 
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Author (Year)  Research Question 
Study 
Design/Framework 
Sample and 
Setting 
Data Collection 
(Instruments/tools) 
Findings 
G., Evans, J., Early, D., 
Fanelli, R., Fisher, D., 
Foley K., Fukami, N., 
Hawang, J., Jain, R., 
Jue, T., Khan, K., 
Lightdale, J., Pasha, S., 
Sharaf, R., Dominitz, J., 
& Cash, B.,(2012) 
providing care to 
breastfeeding patients 
references were 
obtained from the 
bibliographies of the 
identified articles. 
Recommendations of 
expert consultants are 
included as well. 
recommendations is based 
on aggregate evidence & 
assessment of the 
anticipated benefits & 
harms. 
least 4 hours 
following 
administration  
 
Fentanyl – is 
compatible with 
breastfeeding.  
 
Meperidine – 
compatible w/ 
breastfeeding, 
however alternative 
such as fentanyl is 
preferred. 
 
Propofol no 
interruption of 
breastfeeding 
recommended  
 
Sachs, H. C. (2013).  Discussion regarding 
topics of interest 
surrounding lactation  
A clinical report from 
the American Academy 
of Pediatrics 
Update on the transfer 
of drugs and 
therapeutics into 
human breastmilk, the 
expert option of authors 
Clinical report discussing 
lactation & the use of 
psychotropic therapies, 
drugs to treat substance 
abuse, narcotics, 
galactagogues, herbal 
produces, & immunizations 
of breastfeeding women. 
Caution is advised 
for the use of 
codeine & 
hydrocodone in both 
mother & nursing 
infant. 
 
Benefits of 
breastfeeding 
outweigh the risk of 
exposure to most 
therapeutic agents 
via breastmilk.  
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Author (Year)  Research Question 
Study 
Design/Framework 
Sample and 
Setting 
Data Collection 
(Instruments/tools) 
Findings 
Reece-Stremtan, S., 
Campos, M., & 
Kokajko, L. (2017)  
Guidelines for the care of 
breastfeeding mothers & 
infants focus on 
anesthesia & analgesia 
for breastfeeding mothers 
outside the postpartum 
period. 
Clinical protocol  A search of available 
literature as well as up-
to-date information 
about specific 
medications from 
LactMed and other 
internet-based 
websites. 
Appraisal of current 
evidence and information 
about medications 
pharmacologic properties, 
milk levels and rare infant 
effects in case reports. 
Quality of evidence leveled 
based on National 
Guidelines Clearing House 
Resumption of 
normal mentation in 
the mother of a 
healthy term or older 
infant can resume 
breastfeeding with 
no interruption.  
 
Interruption of 
breastfeeding (6-12) 
hours may be 
advised for infants at 
risk for apnea, 
hypotension, or 
hypotonia after 
maternal anesthesia. 
  
Kutlucan, L., Seker, I., 
Demiraran, Y., Ersoy, 
O., Karagoz, I., Sezen, 
G., & Kose, S. A. (2014) 
Is there a delay in the 
onset of lactation in 
patients undergoing 
cesarean section w/ 
general anesthesia when 
compared w/ patients 
who undergo cesarean 
section w/ spinal & 
epidural anesthesia and 
with patients who 
undergo normal vaginal 
birth?  
Randomized cohort 
study  
84 patients, 18-40 years 
of age, ASA I-II  
 
Four groups 
G – general anesthesia 
n:21 
S – spinal anesthesia 
n:21 
E – epidural anesthesia 
n:21 
V – vaginal birth w/ out 
anesthesia n:21 
Pre & post procedure 
oxytocin & prolactin 
values were measured  
  
No significant 
differences amount 
hormone levels in 
the postpartum 
period (9=0.350)  
 
General anesthesia 
w/ propofol 
administration was 
associated w/ 
increased oxytocin 
hormone level.  
 
General anesthesia is 
associated w/ a 
delay in the start of 
lactation (p=0.003) 
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Author (Year)  Research Question 
Study 
Design/Framework 
Sample and 
Setting 
Data Collection 
(Instruments/tools) 
Findings 
Jaafarpour, M., Vasigh, 
A., Khajavikhan, J., & 
Khani, A. (2017) 
Assess the effect of 
ketofol 
(ketamine/propofol 
combination) on pain & 
complications after 
caesarian delivery under 
spinal anesthesia and 
interference w/ 
breastfeeding 
Randomized double-
blinded clinical trial  
92 parturient scheduled 
for elective cesarean 
delivery under spinal 
anesthesia 
 
Four groups:  
1-ketamine 0.25 mg/kg 
2-propofol 0.25 mg/kg  
3-ketofol (25 mg 
ketamine + 25 mg 
propofol) 
4- placebo saline  
Drugs administered 
immediately after clamping 
the umbilical cord.  
 
Visual Analog Scale 
(VAS) was used to 
determine the intensity of 
pain. 
 
SPSS used for data 
analysis, descriptive 
statistics, one-way 
ANOVA, least significant 
difference (LSD) test & 
repeated measurements 
was carried out. P < 0.05 
was considered as 
significant  
Administration of 
ketofol was 
associated w/ reduce 
pain & 
complications after 
cesarean delivery 
and can be 
considered a safe & 
alternative drug for 
lactating women. 
 
Morphine 
consumption, the 
mean score of pain, 
& time of 
breastfeeding was 
significantly lower 
in patients who 
received ketofol 
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